Massive myelinolytic leukoencephalopathy in a patient medicated with low-dose oral methotrexate for rheumatoid arthritis: an autopsy report
Authors:
- 15 March 2007
- journal article
- case report
- Published by Springer Nature in Acta Neuropathologica
- Vol. 114 (4) , 425-430
Abstract
The authors describe a 68-year-old female who developed a rapidly progressing leukoencephalopathy involving the cerebrum and brain stem. The disease appeared during low-dose oral methotrexate (MTX) therapy for rheumatoid arthritis. An extensive clinical investigation discounted other possible causes of white matter lesions. Autopsy identified an uninterrupted severe demyelinating, partially liquefactive necrosis-like lesion in the white matter accompanied by astrogliosis and occasional swollen axons therein. The lesion was generally symmetrical, and distributed throughout the whole cerebral white matter except for the bilateral temporal lobes and the rostral part of the frontal lobes. The internal capsules and cerebral peduncles were spongy, and the central and lateral parts of the pons, especially the transverse cerebellopontine tracts, were affected similarly. It was of note that the lesion was accompanied by neither vascular diseases nor lymphocyte infiltration. Thus, the pathological findings were similar to those of a severe form of central and extrapontine myelinolysis, and clearly different from ordinary MTX leukoencephalopathy reported in patients receiving intrathecal or intravenous MTX therapy, known as “disseminated necrotizing leukoencephalopathy”. Another possibility is that synergistic effects of several white-matter-damaging disorders may have contributed to the hitherto unknown lesion. To our knowledge, this is the first autopsy record that describes an oral MTX-associated neurological disorder.Keywords
This publication has 20 references indexed in Scilit:
- Central and Extrapontine Myelinolysis: Then…and NowJournal of Neuropathology & Experimental Neurology, 2006
- MTX-induced white matter changes are associated with polymorphisms of methionine metabolismNeurology, 2005
- Central Pontine MyelinolysisEuropean Neurology, 2002
- The safety and efficacy of the use of methotrexate in long‐term therapy for rheumatoid arthritisArthritis & Rheumatism, 1986
- Methotrexate therapy in rheumatoid arthritis: 15 years experienceThe American Journal of Medicine, 1983
- Low dose oral methotrexate in rheumatoid arthritis: An uncontrolled trial and review of the literatureSeminars in Arthritis and Rheumatism, 1983
- Effects of chemotherapy on the central nervous system—A study of parenteral methotrexate in long-term survivors of leukemia and lymphoma in childhoodCancer, 1976
- Neurotoxicity and Elevated Cerebrospinal-Fluid Methotrexate Concentration in Meningeal LeukemiaNew England Journal of Medicine, 1973
- Encephalopathy in Acute Leukaemia Associated with Methotrexate TherapyArchives of Disease in Childhood, 1972
- Central Pontine MyelinolysisA.M.A. Archives of Neurology & Psychiatry, 1959